Human CDON/CDO/CDON1 ORF/cDNA clone-Lentivirus particle (NM_001243597)

Cat. No.: vGMLP-SPh-080

Pre-made Human CDON/CDO/CDON1 Lentiviral expression plasmid for CDON lentivirus packaging, CDON lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.

Target products collection

Go to CDON/CDO products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdf MSDS
pdf Datasheet

Product information

Catalog No. Product Name lentivirus Grade lentivirus quantity
vGMLP-SPh-080 Human CDON Lentivirus particle Pilot Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
Research Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMLP-SPh-080
Gene Name CDON
Accession Number NM_001243597
Gene ID 50937
Species Human
Product Type Lentivirus particle (overexpression)
Insert Length 3864 bp
Gene Alias CDO,CDON1,HPE11,ORCAM
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGCATCCGGATCTTGGACCCTTATGTACACTGCTGTATGTTACTCTTACAATTCTGTGCTCTTCTGTGAGTTCAGACTTGGCACCTTATTTTACTTCTGAGCCGCTCTCTGCTGTCCAGAAACTTGGTGGACCTGTAGTACTGCATTGTTCTGCTCAACCTGTGACCACTCGTATCTCATGGCTGCATAACGGAAAAACATTGGATGGAAACCTGGAACATGTTAAGATTCATCAGGGGACTCTGACAATTCTTTCTCTCAACTCCTCTCTTTTGGGTTACTACCAGTGCCTTGCCAACAATAGCATCGGTGCCATTGTGAGTGGCCCTGCGACAGTATCTGTGGCAGTTCTTGGTGATTTTGGTTCATCCACAAAGCATGTTATTACAGCAGAAGAAAAAAGTGCTGGTTTCATTGGCTGCAGGGTACCGGAGAGTAACCCCAAAGCTGAGGTGCGCTATAAAATCCGGGGAAAATGGCTGGAACATTCCACAGAGAATTACTTAATCCTTCCATCAGGAAATCTTCAGATTTTGAATGTATCCTTAGAGGACAAGGGATCATACAAATGTGCAGCTTATAATCCTGTCACACATCAATTAAAAGTTGAACCTATTGGCCGAAAGCTCCTTGTGAGTCGTCCTTCTTCAGATGATGTTCACATTCTTCACCCCACCCATTCACAGGCATTAGCTGTTCTTTCTCGTAGCCCTGTAACCTTGGAGTGTGTGGTGAGTGGGGTCCCGGCTCCTCAAGTGTATTGGCTAAAGGACGGGCAGGACATTGCACCAGGAAGCAACTGGAGAAGGTTGTATTCTCATCTTGCCACTGATAGCGTTGACCCGGCGGACTCCGGAAACTATTCCTGCATGGCGGGAAACAAGTCTGGAGATGTAAAATATGTGACTTACATGGTTAATGTACTTGAACATGCTTCCATTTCTAAAGGACTACAGGATCAGATAGTGTCTCTGGGTGCCACAGTACACTTTACCTGCGACGTTCATGGGAACCCAGCCCCCAACTGTACCTGGTTTCACAATGCACAGCCTATTCATCCTTCTGCACGACATCTAACTGCAGGAAACGGACTGAAAATCAGTGGGGTTACTGTGGAAGATGTTGGGATGTATCAGTGTGTAGCAGATAATGGGATTGGATTTATGCACTCTACTGGAAGACTTGAAATTGAAAATGACGGTGGATTCAAGCCAGTTATAATTACGGCACCAGTAAGTGCAAAGGTTGCAGACGGAGACTTTGTTACTCTGTCCTGCAATGCCAGTGGGCTGCCGGTTCCGGTCATTCGTTGGTATGACAGCCATGGATTGATAACCAGCCATCCATCTCAAGTCCTGAGATCGAAATCCCGAAAATCACAGTTATCAAGACCTGAGGGCTTGAACCTGGAGCCTGTGTACTTCGTCCTGTCCCAAGCTGGTGCAAGCTCTCTCCATATTCAGGCTGTGACTCAGGAACATGCGGGGAAATACATCTGCGAAGCTGCAAATGAACATGGTACCACACAGGCAGAAGCATCTCTCATGGTTGTTCCTTTTGAAACAAATACAAAAGCAGAGACAGTCACACTTCCTGATGCTGCTCAGAATGATGACAGAAGTAAGAGAGATGGTTCAGAAACTGGGTTACTGAGCTCATTTCCGGTGAAGGTCCATCCCAGTGCAGTGGAATCAGCACCAGAGAAAAACGCCAGCGGCATCTCTGTTCCTGATGCCCCCATCATACTGAGCCCCCCACAGACCCACACACCAGACACGTACAACCTGGTGTGGAGGGCAGGCAAGGATGGTGGGCTGCCCATCAATGCTTACTTTGTGAAGTATCGAAAGCTGGATGATGGGGTTGGCATGCTGGGAAGCTGGCACACGGTTCGAGTCCCAGGAAGTGAAAATGAGCTCCATTTAGCTGAGCTGGAGCCATCTAGTCTTTATGAAGTCTTGATGGTAGCAAGAAGCGCAGCAGGTGAAGGCCAACCTGCCATGCTTACCTTCCGAACCAGCAAAGAAAAAACAGCGTCATCAAAAAACACCCAGGCATCCTCTCCACCCGTGGGCATCCCTAAGTATCCCGTTGTTTCAGAGGCTGCAAACAACAATTTTGGAGTGGTACTTACAGATTCCTCTAGGCACAGTGGAGTTCCAGAGGCACCAGATCGGCCTACCATCTCCACTGCATCAGAGACATCAGTCTATGTCACTTGGATTCCTCGGGCAAACGGGGGTTCTCCAATCACTGCCTTCAAAGTCGAATATAAACGGATGAGGACCAGCAATTGGCTGGTGGCAGCTGAAGACATCCCTCCTTCCAAACTTTCAGTGGAAGTTCGTAGTTTAGAACCAGGTTCAACATACAAATTTAGGGTCATTGCCATCAACCATTATGGTGAGAGTTTTCGGAGTTCAGCATCTCGTCCTTATCAAGTGGTTGGGTTCCCCAATCGCTTTTCCAGCCGTCCAATAACTGGACCTCACATTGCATACACAGAGGCTGTCAGCGATACTCAGATCATGCTAAAGTGGACGTACATTCCATCAAGTAACAATAACACTCCCATTCAAGGATTTTATATCTATTACCGACCAACAGATAGTGACAATGACAGTGATTACAAGAGGGATGTTGTAGAAGGTTCAAAGCAGTGGCACATGATTGGCCACCTGCAGCCAGAAACCTCCTATGACATTAAAATGCAATGCTTCAATGAAGGAGGAGAAAGTGAATTTAGCAATGTGATGATCTGCGAGACTAAAGTGAAACGTGTTCCTGGAGCTTCTGAATATCCTGTCAAAGACTTGAGTACCCCTCCAAATTCTTTGGGAAGTGGAGGAAATGTGGGGCCTGCAACCAGCCCTGCCAGAAGCAGTGACATGTTATATCTGATCGTTGGCTGTGTGCTGGGCGTCATGGTCCTCATTCTGATGGTTTTCATTGCAATGTGCCTGTGGAAGAATCGCCAGCAGAATACCATACAAAAATATGACCCACCAGGATATCTCTACCAAGGATCAGATATGAACGGGCAGATGGTGGACTACACCACTCTCTCAGGAGCAAGTCAGATAAATGGAAATGTTCACGGAGGCTTCCTAACCAATGGCGGTCTCAGCAGTGGCTATTCCCACCTTCACCATAAGGTCCCCAATGCAGTCAATGGAATTGTGAATGGGAGCCTAAATGGAGGGCTTTACTCCGGGCACAGCAACTCTCTAACCAGGACACACGTGGATTTTGAACATCCTCATCATCTAGTGAATGGTGGTGGAATGTACACGGCCGTGCCTCAGATTGACCCTCTGGAGTGTGTTAACTGCCGAAATTGTCGAAACAACAATAGGTGTTTCACCAAAACCAACAGCACTTTCAGCAGCAGCCCTCCTCCTGTGGTCCCTGTGGTAGCACCTTATCCTCAGGATGGTTTGGAAATGAAGCCCCTCAGTCACGTGAAGGTGCCTGTATGCCTGACTTCCGCAGTCCCTGATTGTGGCCAGTTGCCGGAGGAGAGCGTCAAGGACAATGTGGAACCAGTCCCTACTCAGCGTACCTGCTGTCAGGACATTGTAAATGACGTCAGCTCTGATGGCTCAGAAGATCCAGCAGAGTTCAGCAGAGGTCAGGAAGGCATGATCAACCTTAGGATTCCAGATCATCTTCAGTTAGCTAAGAGCTGTGTATGGGAAGGAGACAGCTGTGCCCATTCAGAAACAGAGATCAACATTGTAAGTTGGAATGCTCTTATTTTGCCACCTGTCCCCGAGGGCTGTGCTGAGAAGACAATGTGGTCTCCACCTGGCATTCCTTTAGACAGCCCGACAGAGGTCCTTCAGCAGCCCCGGGAAACCTGA
ORF Protein Sequence MHPDLGPLCTLLYVTLTILCSSVSSDLAPYFTSEPLSAVQKLGGPVVLHCSAQPVTTRISWLHNGKTLDGNLEHVKIHQGTLTILSLNSSLLGYYQCLANNSIGAIVSGPATVSVAVLGDFGSSTKHVITAEEKSAGFIGCRVPESNPKAEVRYKIRGKWLEHSTENYLILPSGNLQILNVSLEDKGSYKCAAYNPVTHQLKVEPIGRKLLVSRPSSDDVHILHPTHSQALAVLSRSPVTLECVVSGVPAPQVYWLKDGQDIAPGSNWRRLYSHLATDSVDPADSGNYSCMAGNKSGDVKYVTYMVNVLEHASISKGLQDQIVSLGATVHFTCDVHGNPAPNCTWFHNAQPIHPSARHLTAGNGLKISGVTVEDVGMYQCVADNGIGFMHSTGRLEIENDGGFKPVIITAPVSAKVADGDFVTLSCNASGLPVPVIRWYDSHGLITSHPSQVLRSKSRKSQLSRPEGLNLEPVYFVLSQAGASSLHIQAVTQEHAGKYICEAANEHGTTQAEASLMVVPFETNTKAETVTLPDAAQNDDRSKRDGSETGLLSSFPVKVHPSAVESAPEKNASGISVPDAPIILSPPQTHTPDTYNLVWRAGKDGGLPINAYFVKYRKLDDGVGMLGSWHTVRVPGSENELHLAELEPSSLYEVLMVARSAAGEGQPAMLTFRTSKEKTASSKNTQASSPPVGIPKYPVVSEAANNNFGVVLTDSSRHSGVPEAPDRPTISTASETSVYVTWIPRANGGSPITAFKVEYKRMRTSNWLVAAEDIPPSKLSVEVRSLEPGSTYKFRVIAINHYGESFRSSASRPYQVVGFPNRFSSRPITGPHIAYTEAVSDTQIMLKWTYIPSSNNNTPIQGFYIYYRPTDSDNDSDYKRDVVEGSKQWHMIGHLQPETSYDIKMQCFNEGGESEFSNVMICETKVKRVPGASEYPVKDLSTPPNSLGSGGNVGPATSPARSSDMLYLIVGCVLGVMVLILMVFIAMCLWKNRQQNTIQKYDPPGYLYQGSDMNGQMVDYTTLSGASQINGNVHGGFLTNGGLSSGYSHLHHKVPNAVNGIVNGSLNGGLYSGHSNSLTRTHVDFEHPHHLVNGGGMYTAVPQIDPLECVNCRNCRNNNRCFTKTNSTFSSSPPPVVPVVAPYPQDGLEMKPLSHVKVPVCLTSAVPDCGQLPEESVKDNVEPVPTQRTCCQDIVNDVSSDGSEDPAEFSRGQEGMINLRIPDHLQLAKSCVWEGDSCAHSETEINIVSWNALILPPVPEGCAEKTMWSPPGIPLDSPTEVLQQPRET

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-MP0245-Ab Anti-CDON/ CDO1/ HPE11 monoclonal antibody
    Target Antigen GM-Tg-g-MP0245-Ag CDON VLP (virus-like particle)
    ORF Viral Vector pGMLP-SPh-080 Human CDON Lentivirus plasmid
    ORF Viral Vector pGMAP-SPh-220 Human CDON Adenovirus plasmid
    ORF Viral Vector vGMLP-SPh-080 Human CDON Lentivirus particle
    ORF Viral Vector vGMAP-SPh-220 Human CDON Adenovirus particle


    Target information

    Target ID GM-MP0245
    Target Name CDON
    Gene Group Identifier
    （Target Gene ID in Homo species)         		50937
    Gene ID 100064474 (Equus caballus), 101087264 (Felis catus), 489296 (Canis lupus familiaris), 50937 (Homo sapiens)
    50938 (Rattus norvegicus), 536011 (Bos taurus), 57810 (Mus musculus), 714039 (Macaca mulatta)
    Gene Symbols & Synonyms CDON,Cdon,CDO,Ihog,CDON1,HPE11,ORCAM,Cdo,Cd0,Orcam
    Target Alternative Names CDON,Cell adhesion molecule-related/down-regulated by oncogenes,CDO,Ihog,CDON1,HPE11,ORCAM
    Uniprot Accession O35158,Q32MD9,Q4KMG0
    Additional SwissProt Accessions: Q4KMG0,O35158,Q32MD9
    Uniprot Entry Name
    Protein Sub-location Transmembrane Protein
    Category
    Disease
    Disease from KEGG
    Gene Ensembl ENSECAG00000017335, ENSCAFG00845009814, ENSG00000064309, ENSBTAG00000009315, ENSMUSG00000038119, ENSMMUG00000007628
    Target Classification


    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.